Biomolecular interactions with nanoparticles : applications for coronavirus disease 2019

Farouq, Mohammed A.H. and Al Qaraghuli, Mohammed M. and Kubiak-Ossowska, Karina and Ferro, Valerie A. and Mulheran, Paul A. (2021) Biomolecular interactions with nanoparticles : applications for coronavirus disease 2019. Current Opinion in Colloid and Interface Science, 54. 101461. ISSN 1359-0294 (https://doi.org/10.1016/j.cocis.2021.101461)

[thumbnail of Farouq-etal-2021-COCIS-2021-Biomolecular-interactions-with-nanoparticles-applications]
Preview
Text. Filename: Farouq_etal_2021_COCIS_2021_Biomolecular_interactions_with_nanoparticles_applications.pdf
Accepted Author Manuscript
License: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 logo

Download (1MB)| Preview

Abstract

Nanoparticles are small particles sized 1–100 nm, which have a large surface-to-volume ratio, allowing efficient adsorption of drugs, proteins, and other chemical compounds. Consequently, functionalized nanoparticles have potential diagnostic and therapeutic applications. A variety of nanoparticles have been studied, including those constructed from inorganic materials, biopolymers, and lipids. In this review, we focus on recent work targeting the severe acute respiratory syndrome coronavirus 2 virus that causes coronavirus disease (COVID-19). Understanding the interactions between coronavirus-specific proteins (such as the spike protein and its host cell receptor angiotensin-converting enzyme 2) with different nanoparticles paves the way to the development of new therapeutics and diagnostics that are urgently needed for the fight against COVID-19, and indeed for related future viral threats that may emerge.